The Record Funding Year Is Not Funding You

Global venture funding hit a record $510 billion in the first half of 2026, and most recurring-revenue technology companies will see none of it. The headline describes a market that has quietly closed to any software company without an AI story, and founders who read "record year" as "easy round" are about to price their own dilution off a number that was never available to them.

The record belongs to two companies

The $510 billion first half surpassed the $440 billion invested in all of 2025. It is the largest six-month total on record. It is also the most concentrated ever measured: two frontier AI companies raised $217 billion between them, 43% of every venture dollar deployed in the first half, leaving $293 billion, 57%, for every other company on earth. In the second quarter, more than 70% of all capital went to AI-focused companies, up from just under 50% a year earlier. Sixteen billion-dollar rounds absorbed 53% of the quarter's total.

Strip the frontier labs out and the picture inverts. The number of active investors has fallen, deal counts outside AI have contracted, and the realistic pool of capital for a $3 million ARR vertical software company is smaller today than it was two years ago, not larger. The record is real. It just is not addressed to most of the market.

What the founder believes, and what the term sheet will say

A founder reads "record funding" and assumes the round will be competitive and fairly priced. The market they actually walk into is the opposite. Public application software has repriced to roughly 3.3x forward revenue, down from a five-year average above 7x. Private valuations for anything outside the AI narrative follow the public comps down. An equity round raised into that reprice sells more of the company for the same dollars: at half the multiple, the same $5 million check costs twice the ownership it would have cost at the prior average.

That is the trap inside the record. The founder is not choosing between a good round and a great one. The choice is between selling equity at a discount the founder believes is wrong, and finding capital that prices the business on what it actually is.

The business is more fundable than the multiple suggests

A recurring-revenue technology company with contracted revenue, proven retention, and gross margins above 50% is a strong credit even when its equity multiple is compressed. The equity market is pricing sentiment on the category. The contract base is not sentiment. It is booked, recurring, and forecastable, which is exactly what a lender underwrites and exactly what a discounted equity round ignores.

This is why the capital-structure decision matters more in a concentrated market than in a loose one. When equity was cheap, dilution was a manageable cost of speed. At a compressed multiple, every point of equity given away is expensive, permanent, and paid out of the founder's eventual exit. Debt structured on the revenue itself changes the math without touching the cap table.

How Thalos Capital Approaches This

Thalos Capital originates Recurring Revenue Debt for recurring-revenue technology companies in the United States and Canada, structured around ARR rather than hard assets. There are two structures. The Amortized Term Facility runs three to six years, with principal that ladders up as revenue grows, for companies from $2 million to $20 million in ARR. The Interest-Only Facility runs two to three years, interest-only with a balloon at term end, for companies at $5 million ARR and above. Common eligibility is straightforward: a recurring-revenue technology business, proven product-market fit with ten or more clients, and gross margin above 50%.

The work is borrower-side. Thalos Capital analyzes the contract base, the retention profile, and the growth plan, structures the facility against them, and brings the options from a capital network that underwrites recurring revenue directly. There is no dilution, no board seat, and no warrant. The founder funds the same growth or extends the same runway, and keeps the equity the market is currently mispricing.

Debt is not free and it is not right for every company. A business still searching for product-market fit should not carry fixed obligations. But for a company with real contracted revenue and a clear use of proceeds, non-dilutive debt funds the plan at a fraction of the ownership cost of an equity round raised into a discount.

The cost of reading the headline wrong

The founder who takes the record at face value raises equity at a compressed multiple, gives away ownership that the exit will reprice upward, and does it in a market where the equity was never the point. The one who reads the concentration correctly funds the business on its contracts and waits for the multiple to recover before selling any of it. The difference is measured in points of the company, permanently.

Most financing situations have more options than the borrower initially sees. A conversation is enough to map them. Submit your financing request at https://thaloscapital.com/contact.